BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

870 related articles for article (PubMed ID: 15147530)

  • 1. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
    Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
    J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases.
    Cherif H; Landgren O; Konradsen HB; Kalin M; Björkholm M
    Vaccine; 2006 Jan; 24(1):75-81. PubMed ID: 16107293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response to pneumococcal vaccine in splenectomized children.
    Pedersen FK
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):169-80. PubMed ID: 6880749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia.
    Hedlund JU; Kalin ME; Ortqvist AB; Henrichsen J
    Arch Intern Med; 1994 Sep; 154(17):1961-5. PubMed ID: 8074600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type-specific antibodies to pneumococcal capsular polysaccharide acquired either naturally or after vaccination with Prevenar in children with underlying chronic or recurrent lung diseases.
    Navarro D; Escribano A; Cebrián L; Gimeno C; García-Maset L; García-de-Lomas J;
    Clin Vaccine Immunol; 2006 Jun; 13(6):665-70. PubMed ID: 16760325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults.
    Musher DM; Manof SB; Liss C; McFetridge RD; Marchese RD; Bushnell B; Alvarez F; Painter C; Blum MD; Silber JL
    J Infect Dis; 2010 Feb; 201(4):516-24. PubMed ID: 20092407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil.
    Brandão AP; de Oliveira TC; de Cunto Brandileone MC; Gonçalves JE; Yara TI; Simonsen V
    Vaccine; 2004 Dec; 23(6):762-8. PubMed ID: 15542200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal study of class and subclass antibody response to pneumococcal vaccination in splenectomized individuals with special reference to patients with Hodgkin's disease.
    Grimfors G; Söderqvist M; Holm G; Lefvert AK; Björkholm M
    Eur J Haematol; 1990 Aug; 45(2):101-8. PubMed ID: 2209812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine.
    Smets F; Bourgois A; Vermylen C; Brichard B; Slacmuylders P; Leyman S; Sokal E
    Vaccine; 2007 Jul; 25(29):5278-82. PubMed ID: 17576024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years.
    Manoff SB; Liss C; Caulfield MJ; Marchese RD; Silber J; Boslego J; Romero-Steiner S; Rajam G; Glass NE; Whitney CG; Carlone GM
    J Infect Dis; 2010 Feb; 201(4):525-33. PubMed ID: 20088694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and immunogenicity of Pneumo-23 and ACT-HIB in patients undergoing splenectomy.
    Uslu A; Yetiş H; Aykas A; Karagöz A; Doğan M; Simşek C; Nart A; Yüzbaşioğlu MF
    Ulus Travma Acil Cerrahi Derg; 2006 Oct; 12(4):277-81. PubMed ID: 17029117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
    J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation.
    Cordonnier C; Labopin M; Chesnel V; Ribaud P; De La Camara R; Martino R; Ullmann AJ; Parkkali T; Locasciulli A; Yakouben K; Pauksens K; Einsele H; Niederwieser D; Apperley J; Ljungman P;
    Clin Infect Dis; 2009 May; 48(10):1392-401. PubMed ID: 19368505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type-specific anti-pneumococcal antibody subclass response to vaccination after splenectomy with special reference to lymphoma patients.
    Grimfors G; Björkholm M; Hammarström L; Askergren J; Smith CI; Holm G
    Eur J Haematol; 1989 Nov; 43(5):404-10. PubMed ID: 2612613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Missing spleen: indication for pneumococcal vaccination].
    van Dijk GW; van Leeuwen HJ; van Gijn J; Hoepelman IM
    Ned Tijdschr Geneeskd; 2003 Mar; 147(10):425-8. PubMed ID: 12666509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pneumococcal vaccination of splenectomized patients. Recommendations based on a 10-year experience].
    Konradsen HB; Henrichsen J
    Ugeskr Laeger; 1991 Oct; 153(43):2999-301. PubMed ID: 1801383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin classes and persistence of anti-pneumococcal antibodies in splenectomized adults and adolescents after pneumococcal vaccination.
    Pedersen FK; Nielsen JL; Ellegaard J
    Acta Pathol Microbiol Immunol Scand C; 1983 Aug; 91(4):245-9. PubMed ID: 6637480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
    Hedlund J
    Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preserved antibody levels and loss of memory B cells against pneumococcus and tetanus after splenectomy: tailoring better vaccination strategies.
    Rosado MM; Gesualdo F; Marcellini V; Di Sabatino A; Corazza GR; Smacchia MP; Nobili B; Baronci C; Russo L; Rossi F; Vito RD; Nicolosi L; Inserra A; Locatelli F; Tozzi AE; Carsetti R
    Eur J Immunol; 2013 Oct; 43(10):2659-70. PubMed ID: 23813052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological responses to pneumococcal vaccine in frail older people.
    Ridda I; Macintyre CR; Lindley R; Gao Z; Sullivan JS; Yuan FF; McIntyre PB
    Vaccine; 2009 Mar; 27(10):1628-36. PubMed ID: 19100304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.